Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes
- PMID: 22541596
- PMCID: PMC3337270
- DOI: 10.1186/2041-1480-3-S1-S5
Annotation Analysis for Testing Drug Safety Signals using Unstructured Clinical Notes
Abstract
Background: The electronic surveillance for adverse drug events is largely based upon the analysis of coded data from reporting systems. Yet, the vast majority of electronic health data lies embedded within the free text of clinical notes and is not gathered into centralized repositories. With the increasing access to large volumes of electronic medical data-in particular the clinical notes-it may be possible to computationally encode and to test drug safety signals in an active manner.
Results: We describe the application of simple annotation tools on clinical text and the mining of the resulting annotations to compute the risk of getting a myocardial infarction for patients with rheumatoid arthritis that take Vioxx. Our analysis clearly reveals elevated risks for myocardial infarction in rheumatoid arthritis patients taking Vioxx (odds ratio 2.06) before 2005.
Conclusions: Our results show that it is possible to apply annotation analysis methods for testing hypotheses about drug safety using electronic medical records.
Figures
References
-
- Classen D, Resar R, Griffin F, Federico F, Frankel T, Kimmel N, Whittington J, Frankel A, Seger A, James B. 'Global trigger tool' shows that adverse events in hospitals may be ten times greater than previously measured. Health affairs (Project Hope) 2011;30(4):581–589. doi: 10.1377/hlthaff.2011.0190. - DOI - PubMed
-
- Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA : the journal of the American Medical Association. 1997;277(4):307–311. doi: 10.1001/jama.1997.03540280045032. - DOI - PubMed
-
- Graham D, Campen D, Hui R, Spence M, Cheetham C, Levy G, Shoor S, Ray W. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. The Lancet. 2005;365(9458):475–481. - PubMed
-
- The Ten Worst Drug Recalls In The History Of The FDA. http://247wallst.com/2010/12/10/the-ten-worst-drug-recalls-in-the-histor...
-
- The Sentinel Initiative July 2010 Report. FDA; 2010.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
